Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma

Publication Date

2024

Content Type

Article

PubMed ID:

38400780

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS